PubMed Health⌕ Search
Home/Archive/PubMed

PubMed · 616668

Conventional assay systems for interferon.

H K Oie
View original source ↗Export metadata ↓

Abstract

The continuous appearance in the literature of new and modified assays for interferon indicates the lack of a universally acceptable assay. Recent reports show a tendency for simple, rapid, and economical assays with capabilities for the assay of interferons from many animal species. The EMC HA yield reduction assay, the neuraminidase yield reduction method, and the radiochemical assay have many desirable features. These assays have the potential of displacing the presently used conventional bioassays.

Explore related subjects

Cytopathogenic Effect, ViralHemadsorption Inhibition TestsHemagglutination Inhibition TestsInterferonsMethodsNeuraminidaseRNA, ViralViral Plaque AssayVirus ReplicationVirusesJournal Article

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

H K Oie. 1977. Conventional assay systems for interferon.. https://pubmed.ncbi.nlm.nih.gov/616668/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed1992

Differentiation of the four viruses of the sugarcane mosaic virus subgroup based on cytopathology.

A cytological comparison has been made of representative isolates of johnsongrass mosaic (JGMV), maize dwarf mosaic (MDMV), sorghum mosaic (SrMV) and sugarcane mosaic (SCMV) viruses. These four viruses now encompass the complex of virus strains which were formerly considered as strains of sugarcane mosaic and/or maize dwarf mosaic viruses. The structure of the cytoplasmic cylindrical inclusions induced by these viruses, together with other cytological alterations, allow the four viruses to be distinguished. Pinwheels, scrolls and laminated aggregates were produced only by SCMV whereas JGMV, MDMV, and SrMV produced only pinwheels and scrolls. SrMV produced amorphous cytoplasmic inclusions which are not produced by JGMV and MDMV. The latter two were rather similar in cytological effects except that the SCMV-JG (U.S.A.) isolate of MDMV produced aggregates of needle-like structures in the cytoplasm which were not found with JGMV and the other MDMV isolates. The specific cytological effects induced by these viruses thus corroborate the recent classification of these viruses based mainly on the properties of the coat-protein gene, the 3' noncoding nucleotide sequences, and host reactions.

Cytopathogenic Effect, Viral↗
PubMed1992

HIV-1 biological phenotype and the development of zidovudine resistance in relation to disease progression in asymptomatic individuals during treatment.

OBJECTIVE: To determine which parameters are associated with clinical progression during zidovudine treatment of asymptomatic HIV-1-infected individuals. METHODS: Twenty-four initially asymptomatic HIV-1-infected individuals were treated with zidovudine and followed until the development of AIDS or for approximately 3 years. HIV-1 phenotype was determined by cocultivation of patient cells with donor lymphocytes, and by a new assay of direct cocultivation with MT-2 cells. Specific mutations in the HIV-1 reverse transcriptase (RT) gene conferring resistance to zidovudine were detected using a selective polymerase chain reaction. RESULTS: Progression to AIDS was more rapid in individuals harbouring syncytium-inducing (SI) viral isolates or showing a conversion from non-syncytium-inducing (NSI) to SI viral isolates. One out of 20 patients who spent a total of 559 months harbouring an NSI phenotype progressed to AIDS, whereas eight out of 12 patients who spent a total of 223 months harbouring an SI phenotype progressed to AIDS (P < 0.001). There was no significant difference between SI and non-SI isolates in the frequency of five mutations causing zidovudine resistance. However, all SI isolates obtained after 2 years of treatment contained mutations in codons 41 and 215 of the RT gene, whereas only five out of 11 (45%) NSI isolates obtained at that time had this combination of mutations. CONCLUSIONS: Conversion to the SI phenotype cannot be prevented by zidovudine treatment. The presence or appearance of an SI virus heralded disease progression in zidovudine-treated individuals. Further research is required to investigate the relationship between virus phenotype and development of zidovudine resistance.

Cytopathogenic Effect, Viral↗